antitumor antibiotic
This page covers all antitumor antibiotic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting DNA topoisomerase II.
Targets
Phase 2 pipeline (1)
- Aldoxorubicin HCl · ImmunityBio, Inc. · Oncology
Aldoxorubicin HCl is a prodrug that selectively releases doxorubicin in acidic environments, such as tumor cells, to exert its cytotoxic effects.
Patent intelligence
- antitumor antibiotic patent landscape — aggregated cliff calendar, attackable patents, originator estates